http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2397761-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748
filingDate 2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b10d512762dfdb9652841cf8aaa4e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665813080ace97bace240ca209e86c71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f4c35cd68bb708b84c3adc07125b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043f248504480bc1ee6568d80623b934
publicationDate 2010-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2397761-C2
titleOfInvention Method of reducing pathologic attraction to alcohol in post abstinent period
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, in particular to addictology, and deals with reduction of pathological attraction to alcohol in post abstinent period. For this purpose daily 40-50 minutes before subcutaneous introduction of apomorphine hydrochloride furosemide in dose 40 mg is administered for 9 days. n EFFECT: method ensures acceleration in development of stable reaction of disgust for alcohol and reduction of course dose of apomorphine. n 2 tbl, 1 ex
priorityDate 2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448339016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25058166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440

Total number of triples: 24.